Zevra Therapeutics, Inc. Total Long-Term Debt
Zevra Therapeutics, Inc. (ZVRA) had Total Long-Term Debt of $61.93 million as of 2025-12-31, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Debt › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2026-08-05
- 2025-12-31: Long-term Debt $61.93M.
- 2025-09-30: Long-term Debt $61.31M.
- 2025-06-30: Long-term Debt $60.69M.
- 2024-12-31: Long-term Debt $59.50M.
| Period end | Long-term Debt |
|---|---|
| 2025-12-31 | $61.93M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $61.31M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $60.69M 10-Q · filed 2025-08-12 |
| 2024-12-31 | $59.50M 10-K · filed 2026-03-09 |
| 2020-12-31 | $67.66M 10-K · filed 2021-03-12 |
| 2020-09-30 | $65.92M 10-Q · filed 2020-10-30 |
| 2020-06-30 | $67.27M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $68.61M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $77.34M 10-K · filed 2021-03-12 |
| 2018-12-31 | $81.44M 10-K · filed 2020-02-28 |
| 2017-12-31 | $92.73M 10-K · filed 2018-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |